SC 13G: Mind Medicine (MindMed) Inc.
Ticker: DFTX · Form: SC 13G · Filed: Mar 21, 2024 · CIK: 1813814
| Field | Detail |
|---|---|
| Company | Mind Medicine (Mindmed) Inc. (DFTX) |
| Form Type | SC 13G |
| Filed Date | Mar 21, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Mind Medicine (MindMed) Inc..
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Mind Medicine (Mindmed) Inc. (ticker: DFTX) to the SEC on Mar 21, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
How long is this filing?
Mind Medicine (Mindmed) Inc.'s SC 13G filing is 4 pages with approximately 1,232 words. Estimated reading time is 5 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,232 words · 5 min read · ~4 pages · Grade level 13.6 · Accepted 2024-03-21 16:05:38
Filing Documents
- formsc13g.htm (SC 13G) — 92KB
- 0001493152-24-010780.txt ( ) — 93KB
for additional information
Item 4 for additional information. CUSIP No. 60255C885 SCHEDULE 13G 1 NAME OF REPORTING PERSONS Commodore Capital Master LP 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 5,833,333* 7 SOLE DISPOSITIVE POWER 0 8 SHARED DISPOSITIVE POWER 5,833,333* 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,833,333* 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.3%* 12 TYPE OF REPORTING PERSON OO *See
for additional information
Item 4 for additional information. CUSIP No. 60255C885 SCHEDULE 13G Item 1. (a) Name of Issuer Mind Medicine (MindMed) Inc. (the “Issuer”) Item 1. (b) Address of Issuer’s Principal Executive Offices One World Trade Center, Suite 8500, New York, New York 10007 Item 2. (a, b, c) Names of Person Filing, Address of Principal Business Office, Citizenship: This report on Schedule 13G is being filed by Commodore Capital LP, a Delaware limited partnership (the “Firm”) and Commodore Capital Master LP, a Cayman Islands exempted limited partnership (“Commodore Master”). The address for the Firm and Commodore Master is: 444 Madison Avenue, Floor 35, New York, New York 10022. Item 2. (d) Title of Class of Securities Common Shares, no par value per share (the “Common Shares”) Item 2. (e) CUSIP No.: 60255C885 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person filing is a: N/A CUSIP No. 60255C885 SCHEDULE 13G Item 4. As reported in the cover pages to this report, the ownership information with respect to the Firm is as follows: (a) Amount Beneficially Owned: 5,833,333* (b) Percent of Class: 8.3%* (c) Number of Shares as to which such person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 5,833,333* (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 5,833,333* As reported in the cover pages to this report, the ownership information with respect to Commodore Master is as follows: (a) Amount Beneficially Owned: 5,833,333* (b) Percent of Class: 8.3%* (c) Number of Shares as to which such person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 5,833,333* (iii) Sole power to dispose or to direct the disposition of: 0 (iv)